Shares of Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report) shot up 13.3% on Tuesday . The company traded as high as GBX 2.38 and last traded at GBX 2.38. 748,364 shares traded hands during mid-day trading, a decline of 23% from the average session volume of 973,726 shares. The stock had previously closed at GBX 2.10.
Cizzle Biotechnology Price Performance
The stock has a 50 day moving average of GBX 1.74 and a two-hundred day moving average of GBX 1.62. The company has a debt-to-equity ratio of -54.35, a quick ratio of 4.66 and a current ratio of 0.48. The firm has a market capitalization of £9.08 million, a P/E ratio of -7.16 and a beta of 0.51.
Cizzle Biotechnology Company Profile
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.
Featured Articles
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
